Radiographic scoring in rheumatoid arthritis - The basics

Slides:



Advertisements
Similar presentations
ACR Criteria in Determining Progression of RA StageClinical and Radiologic Criteria Stage 1Early RA No destructive changes observed upon roentgenographic.
Advertisements

Hatem H Eleishi, MD Professor of Rheumatology, Cairo University Consultant Rheumatologist, Dr. Soliman Fakeeh Hospital Rheumatoid Arthritis Wednesday,
Drug Therapy for Rheumatoid Arthritis in Adults Prepared for: Agency for Healthcare Research and Quality (AHRQ)
Efficacy of Methotrexate and/or Etanercept for treatment of RA Rheumatoid Arthritis:
A quantitative approach to accurate classification of RA. Tom Huizinga.
Patients with Rheumatoid Arthritis in Comparison to Other Connective Tissue Diseases Are Mostly Influenced by Concomitant Fibromyalgia Tomš J, Daňková.
1 Rheumatoid Arthritis M Handel 1 st Feb Rheumatoid Arthritis is a multi-system autoimmune disease of unknown cause characterized by inflammatory.
Achy shoulders and a very high CRP Sarah Tansley Rheumatology, Clinical Fellow.
Table 1. Comparison between the provisional diagnosis based on the proforma versus final diagnosis Early arthritis Rheumatoid arthritis 3 6 Psoriatic.
IMPROVING EARLY DIAGNOSIS AND TREATMENT OF RHEUMATOID ARTHRITIS Michael Lockwood, MD, FACP, FACR Rheumatology Indiana University Health Arnett.
CLINICAL CASES. Case 1: Mr. OA Mr. OA: Case Presentation 62-year-old lawyer Mild left knee pain for 3 month, but became worse 1 week ago No swelling.
What is the definition of remission in RA? American Rheumatism Association (ARA)¹ Five or more of the following criteria must be fulfilled for at least.
Remission in Established RA Patients
Measuring Signs and Symptoms in Rheumatoid Arthritis David R. Karp, MD, PhD Chief, Rheumatic Diseases UT Southwestern Medical Center David R. Karp, MD,
Patient Questionnaires Tutorial: Review of MDHAQ and score RAPID3
Rheumatoid Arthritis Anila Malik GPVTS. Aims To cover the following: What is RA? Diagnostic criteria and clinical features Rheumatoid Factor Investigations.
Rheumatoid Arthritis(RA)
Rituximab for the Treatment of Rheumatoid Arthritis
Rheumatoid Arthritis of the Cervical Spine Zikou Anastasia Radiology Department University Hospital of Ioannina.
Patient questionnaires: Standardized quantitative “scientific” data from a patient history, the primary source of rheumatology treatment decisions Theodore.
Yusuf Yazıcı, MD NYU Hospital for Joint Diseases
Achieving remission in early RA Dubai, United Arab Emirates 19. January 2009 Professor Joachim Kalden Friedrich-Alexander University Erlangen-Nuremberg.
Cognitive Impairment: An Independent Predictor of Excess Mortality SACHS, CARTER, HOLTZ, ET AL. ANN INTERN MED, SEP, 2011;155: ZACHARY LAPAQUETTE.
PsA: Review of Available Assessment Instruments and Lessons from Trial Results Part II Christian Antoni Friedrich Alexander University Erlangen-Nürnberg.
The Norfolk Arthritis Register Alan Silman arc Epidemiology Unit University of Manchester UK.
Case #13 Ellen Marie de los Reyes March 15, 2007.
Maxime DOUGADOS Paris-Descartes University, Medicine Faculty; UPRES EA-4058; AP-HP, Cochin Hospital, Rheumatology B Dpt PARIS, France Status versus Changes:
1 Assessing the Minimally Important Difference in Health-Related Quality of Life Scores Ron D. Hays, Ph.D. UCLA Department of Medicine October 25, 2006,
Yusuf Yazıcı, MD NYU Hospital for Joint Diseases, New York
EFFICACY OF SPA THERAPY IN RHEUMATOID ARTHRITIS-A RANDOMISED CONTROLLED CLINICAL STUDY Mine Karagülle Department of Medical Ecology and Hydroclimatology.
Longitudinal databases and registries – why?
Saving time and improving care with a multidimensional health assessment questionnaire: 10 practical considerations T Pincus, Y Yazici, M Bergman J Rheumatol.
Radiological scoring in Psoriatic Arthritis Application of the OMERACT filter to four scoring methods.
Rheumatology teaching session GP ST2 year 8/9/10.
1 Assessing Disease Activity Janice Booth Rheumatology Nurse Practitioner January 2012.
Case Discussion Dr. Raid Jastania. What is the outcome of inflammation?
1 Session 6 Minimally Important Differences Dave Cella Dennis Revicki Jeff Sloan David Feeny Ron Hays.
EQ-5D and SF-36 Quality of Life Measures in Systemic Lupus Erythematosus: Comparisons with RA, Non-Inflammatory Disorders (NIRD), and Fibromyalgia (FM)
Rheumatoid Arthritis Dr Chandini Rao Consultant Rheumatologist.
OMERACT Workshop Outcome Measures in Psoriatic Arthritis
Infectious arthritis Bacterial Viral Other Postinfectious (reactive) arthritis Rheumatic fever Reactive arthritis Enteric infection Other seronegative.
SARAH: Strengthening and Stretching for Rheumatoid Arthritis Affecting the Hand: A randomised controlled trial Adams J, Williams MA, Heine PJ, McConkey.
Outcome Measures in PsA Philip Mease MD Seattle, WA.
Radiological scoring in Psoriatic Arthritis
Radical Prostatectomy versus Watchful Waiting in Early Prostate Cancer Anna Bill-Axelson, M.D., Lars Holmberg, M.D., Ph.D., Mirja Ruutu, M.D., Ph.D., Michael.
Efavirenz Use Not Associated With Depressive Episodes, According to Analysis of Randomized Clinical Trial Outcomes Slideset on: Journot V, Chene G, De.
Recommendation 1: Defining & Diagnosing UPIA. Learning Objectives State the definition of Undifferentiated Peripheral Inflammatory Arthritis (UPIA) Describe.
General Introduction Some Notes. Definition of Measurement “Measurement consists of rules for assigning numbers to observable attributes so as to represent.
A NEW LOOK AT RA Interactive Hot Topics Series
A NEW LOOK AT RA Interactive Hot Topics Series
From: Treatment of Very Early Rheumatoid Arthritis With Symptomatic Therapy, Disease-Modifying Antirheumatic Drugs, or Biologic AgentsA Cost-Effectiveness.
Anti-TNF therapy improves hand function in rheumatoid arthritis
FRAX & ITS ASSOCIATIONS IN RHEUMATOID ARTHRITIS
3e Initiative 2009 How to investigate and follow-up Undifferentiated Peripheral Inflammatory Arthritis? Case 3 1.
New Criteria of RA Esraa Bukhari Houseofficer 29 Nov 2010.
Albarouni, Mohammed 1, Becker, Ingrid 2, Horneff, Gerd 1
FINAL Recommendations
Rhematoid Rthritis Respiratory disorders
Jung-Hua Hsueh, Lee-Wei Chen, M.D., Ph.D
BeSt Study: Patient Characteristics Total Population Female 67% Male % Age (years) Duration of symptoms (weeks) 23 Time diagnosis.
RA also increases the risk for work disability and therefore impacts livelihood. The percentage of RA patients who quit working after only.
Mean DAS (A), HAQ (B) and percentages in low disease activity, DAS remission and drug-free DAS remission (C) during 5 years in the DAS ≤2.4 steered (BeSt)
Additional efficacy outcomes for the 12-week study of Japanese patients with rheumatoid arthritis treated with baricitinib or placebo. Additional efficacy.
Different treatment strategies in rheumatoid arthritis in relation to radiographic progression (A) number of swollen joints (B) and fatigue severity over.
Clinical response in patients with early and established RA at month 24. *p
Changes in erosion score (A), JSN (B), and mean mTSS (C) at years 2, 6, and 10, and percentage of radiographic nonprogressors (D) over time. Changes in.
Acute Phase Reactants in Patients with UPIA
Patient-level radiographic progression of structural joint damage at year 1 and year 2 by original randomisation. Patient-level radiographic progression.
Effect sizes (95% CI) of clinical variables per treatment group of studies directly comparing different dosages/routes. Effect sizes (95% CI) of clinical.
Multivariable model of adjusted
Presentation transcript:

Radiographic scoring in rheumatoid arthritis - The basics Tuulikki Sokka, MD, PhD tuulikki.sokka@ksshp.fi

Learning Objectives History of different scoring methods Basics of the most often used methods Interpretation of radiographic scores in clinical trials Clinical use of radiographs Radiographic outcomes in selected clinical cohorts

History; the main methods Steinbrocker 1949 Kellgren 1956 Sharp 1971 Van der Heijde modification Larsen 1973 modifications

Steinbrocker method Stage I - IV Relates to “anatomic stages” radiographs of hands&wrists The grade is determined by the worst change in any joint Limitations: narrow scale; bias toward the most severely affected joint

Kellgren method 0-4, based on standard set of radiographs “global” – one grade is given as a summation of abnormalities for all the joints in both hands and wrists Limitations: narrow scale; weighted to reflect the most damaged joints

Sharp method (1) Purpose: to develop a quantitative assessment for radiographic changes in RA Included: Hands&wrists

Sharp method (2) Initially, 10 features were analyzed: Periosteal reaction Cortical thinning Osteoporosis Sclerosis Osteophyte formation Defects Cystic changes Surface erosions Joint space narrowing Ankylosis Reason to delete items: Rare Technical problems Secondary changes

Sharp method (2) Initially, 10 features were analyzed: Periosteal reaction Cortical thinning Osteoporosis Sclerosis Osteophyte formation Defects Cystic changes Surface erosions Joint space narrowing Ankylosis Rare Technical problems Secondary changes INCLUDED: Erosion score Joint space narrowing

Sharp method (3) Erosion score; principles: Score 0-5 for each joint one point for each erosion in each joint and 5 for total destruction 29 areas were analyzed in both hands+wrists – maximum possible score: 290

Sharp method (4) Joint space narrowing score; principles 0 - normal 1 - focal narrowing 2 – reduction of <50% of joint space 3 – reduction of >50% of joint space 4 – ankylosis 27 areas in hands and wrists – max score 216

Sharp method (5) How many joints? (1985) Factors to be considered: Frequency of involvement Technical factors Minimum number of joints required in a patient population from mild to severe disease: 17 for erosions 18 for joint space narrowing ….. Still to decrease………………….

Van der Heijde modification of the Sharp score PRINCIPLES Feet included Number of hand joints decreased Scoring for erosions defined

The Sharp/van der Heijde: Joints to be scored for erosions

The Sharp/van der Heijde: Joints to be scored for joints space narrowing

Sharp van der Heijde method (1) Erosions Scoring of the hands: 16 areas included Score 0-5 per joint 1 – for discrete erosions 2-3 for larger erosions depending of the surface area involved 4 if erosion extends over middle of the bone 5 for complete collapse

Sharp van der Heijde method (2) Erosions Scoring of the feet: 10 MTP and 2 IP joints of big toes Score 0-5 per each side of the joint: total 0-10 1 – for discrete erosions 2-3 for larger erosions depending of the surface area involved 4 if erosion extends over middle of the bone 5 for complete collapse

Sharp van der Heijde method (3) JSN, hands, feet Joint space narrowing score; 15 areas for hands, 6 for feet 0 - normal 1 - focal narrowing 2 – reduction of <50% of joint space 3 – reduction of >50% of joint space 4 – ankylosis

Sharp van der Heijde method (4) Total scores: Erosion scores for hands 160 Erosion scores for feet 120 JSN for hands 120 JSN for feet 48 Total 448

Larsen score (1) Background was a clinical observation: “A man with RA Steinbrocker 4 running to a bus” Steinbrocker 4 is maximal damage Max damage and running to a bus do not match A better scoring method needed

Larsen score (2) Reference films for each joint Score 0-5 for each joint Scoring includes JSN and erosions Articular osteoporosis and soft tissue swelling were initially included but omitted later

Larsen score (3) Which joints? Scott 1995: 10 PIPs, 10 MCPs, 10 MTPs, wrists multiplied by 5 – total score 200 Kaarela & Kautiainen 1997: 10 MCPs, II-V MTPs, wrists not multiplied – total score 100

Larsen 0-100

Larsen scoring

Larsen vs. Sharp Are significantly correlated Pincus et al. J Rheumatol 1997 Larsen less time-consuming and easier overall scoring for each joint wrist analyzed as one joint lower number of joints

Smallest Detectable Difference SDD SDD is the smallest change that can be reliably discriminated from the measurement error of the scoring method SDD is based on defining measurement error and 95% limits of agreement Sharp vd Heijde on scale 448; SDD = 5 Larsen on scale 200; SDD = 5.8 Bruynesteyn et al. A&R 2002

Minimal Clinically Important Difference MCID MCID = progression with the highest combined sensitivity and specificity for detecting relevant progression Sharp vd Heijde on scale 448; MCID = 4.6 Larsen on scale 200; MCID = 2.3 In both, roughly 1% of the maximum Bruynesteyn et al. A&R 2002

Radiographic scores in RCTs - interpretations

Radiographic progression in selected clinical trials Yazıcı Y, Yazıcı H, Arthritis Rheum 2006;54(supl)

Low radiographic damage in current RCTs: Table 3. Change from baseline in disease characteristics in the ITT population after 2 years of treatment in the TEMPO trial MTX (n = 206) Etan (n = 202) Etan + MTX (n = 212) Year 2    Total Sharp score (0-448)        Mean (95% CI) 3.34 (1.18, 5.50) 1.10 (0.13, 2.07) -0.56 (-1.05,-0.06)        Median (IQR) 0.00 (-0.11, 2.33) 0.00 (-0.66, 1.08) 0.00 (-1.41, 0.05) vdHeijde A&R2006

Few patients have radiographic damage in current RCTs: Total Sharp vdHeijde score (0-448) in the TEMPO trial over 2 years vdHeijde A&R2006

Measures of RA over time: short term vs. long term Months - years Swollen joint count Tender joint count ESR, CRP Pain Functional capacity Global health by patient Global health by Dr (Radiographic damage; >1yr) = measures of disease activity Long term Years - decades Deformities Radiographic damage Joint replacements Functional capacity Comorbidity Work disability Costs Mortality = measures of outcomes Clinical cohorts, longitudinal observational studies, databases RCTs

Radiographs – clinical use

Two clusters of measures in RA x-rays HAQ joint deformity disease duration pain RF+ joint tenderness joint swelling ESR, CRP age HLA-DR4 patient global work disability mortality Pincus, Sokka. Best Pract Res Clin Rheumatol. 2003

The HAQ, CLINHAQ, or MDHAQ Patient Questionnaire – is Best Predictor in RA of… Functional status (Pincus et al. Arthritis Rheum. 1984, Wolfe et al. J Rheumatol. 1991) Work disability (Borg et al. J Rheumatol 1991, Callahan et al. J Clin Epidemiol. 1992, Wolfe and Hawley. J Rheumatol. 1998, Fex et al. J Rheumatol 1998, Sokka et al. J Rheumatol 1999, Barrett et al. Rheumatology 2000, ) Costs (Lubeck et al. Arthritis Rheum. 1986) Joint replacement surgery (Wolfe and Zwillich. Arthritis Rheum. 1998) Death (Pincus et al. Arthritis Rheum. 1984, Ann Intern Med.1994, Wolfe et al. J Rheumatol 1988, Leigh&Fries J Rheumatol 1991, Wolfe et al. Arthritis Rheum. 1994, Callahan et al. Arthrits Care Res 1996, 1997, Soderlin et al. J Rheumatol 1998, Maiden et al. Ann Rheum Dis 1999, Sokka et al. Ann Rheum Dis 2004)

Larsen & Thoen Scand J Rheumatol 1987 100% 75% 50% 25% 0% Damage score 0-100 0 2 4 6 8 10 12 14 16 18 20 22 24 Disease duration, years

Fuchs et al. J Rheumatol 1989 100% Erosion score 0 - 4.33 75% 50% 25% 0 2 4 6 8 10 12 14 16 18 20 22 24 Disease duration, years

Salaffi & Ferraccioli Scand J Rheumatol 1989 100% 75% 50% 25% 0% Erosion score 0 - 150 0 2 4 6 8 10 12 14 16 18 20 22 24 Disease duration, years

The Jyväskylä Experience The Central Finland RA register includes all patients with diagnosis of RA since 1980’s; prospective in all patients since 1996 2,900 patients; 2,300 alive Covers a population of 265,000

The North Pole

Jyväskylä Central Hospital is the only rheumatology clinic in the Central Finland District and serves a population of 265,000 2 full-time rheumatologists and 1 trainee + 4 other rheumatologists

The Central Finland RA Register Patient demographics History of onset of RA Classification criteria Extra-articular features Comorbidities Relevant surgeries All previous and present DMARDs

Patients with early arthritis All new patients with RA are included; about 100 early RA patients each year Baseline data includes patient self-report questionnaires, structured clinical status, laboratory tests, radiographs of hands and feet

Patient Monitoring in early RA since 1997 Regular out-patient visits in rheumatology unit for 2 years A control visit at 1, 2, 5, and 10 years including patient self-reported outcomes, structured clinical status, update of RA register information, laboratory tests including RF and aCCP, and radiographs of hands and feet

Patient Monitoring Each visit, every patient is asked to complete an extended 2-page HAQ or self-report on a touch screen / GoTreatIT Rheumatologist: a status form / GoTreatIT An annual mailed questionnaire to all patients in the RA Register since 1998 A 5-year follow-up of 2000 population controls in 2000-2005; 2007

Radiographic outcomes in selected clinical cohorts

Radiographic outcomes over 5 years in 3 Jyvaskyla Cohorts: Patients with early RA: 1983-85 1988-89 1995-96

of RF+ patients over 5 years 1995-96 1983-85 1988-89 Larsen scores of RF+ patients over 5 years 1995-96 Each line illustrates Larsen score of each patient Sokka et al. J Rheumatol 2004

Increasing use over time 1988-89 1983-85 DMARDs over 5 years: Increasing use over time 1988-89 Sokka et al. J Rheumatol 2004 1995-96

Radiographic outcomes of RF+ patients over 5 Years in 3 cohorts of patients with early RA. 1983-85 1988-89 1995-96 N 46 53 38 Patients with an erosive disease at 5 years, % 86% 67% 73% Patients with Larsen >=10,% Baseline 9% 0 3% 2 years 40% 20% 8% 5 years 55% 33% 14% Patients in the most recent cohort have potential for an erosive disease but the extent of damage remained low compared to earlier cohorts. Sokka et al. JRheumatol 2004

Radiographic outcomes in two cohorts The Heinola Cohort: 103 patients with early RA in the 1970’s The Jyvaskyla Cohort: 85 patients with early RA in the 1980’s All RF+ 8-year follow-up

Larsen score in the Heinola Cohort vs. Jyvaskyla Cohort over 8 years 26% 12% Disease duration (years) Sokka T, Kaarela K, Mottonen T, Hannonen P. Clin Exp Rheumatol 1999

DMARDs in the later cohort Increased use of DMARDs in the later cohort Heinola 1973-75 103 patients Early RA RF+ Jyvaskyla 1983-89 85 patients Early RA RF+ “saw tooth strategy” Sokka et al CER 1999

Median values with 95% confidence intervals for the Larsen score in patients with <5, 5-15 and > 15 years of disease in 1985 and 2000 in TPclinic T o t a l - 4 5 1 D i s e d u r n ( y ) 2 3 L c p < . Pincus, Sokka, Kautiainen A&R 2005

Contemporary DMARDs in the 1985 Cohort Pincus, Sokka, Kautiainen A&R 2005

Contemporary DMARDs in the 2000 Cohort Pincus, Sokka, Kautiainen A&R 2005

Scoring of x-rays in RCTs vs. in clinical care Experienced assessors read x-rays Observers blinded to clinical data Observers blinded to the order of radiographs Strict methodology to get accurate scores Every clinician to have basic knowledge about x-rays X-rays add to clinical data Serial x-rays to be compared to detect progression/improvement Understanding of radiographic progression

32nd Scandinavian Congress of Rheumatology 30 January - 3 February 2008 Levi, Lapland, Finland Further information: www.congrex.fi/scr2008

To read: van der Heijde D. How to read radiographs according to the Sharp/van der Heijde method. J Rheumatol 1999; 26:743-745. Kaarela K, Kautiainen H. Continuous progression of radiological destruction in seropositive rheumatoid arthritis. J Rheumatol 1997; 24:1285-1287.